Literature DB >> 11422761

Frequency of renal phosphate leak among patients with calcium nephrolithiasis.

D Prié1, V Ravery, L Boccon-Gibod, G Friedlander.   

Abstract

BACKGROUND: Nephrolithiasis is a frequent disorder affecting 10 to 15% of the population in Europe and the United States. More than 80% of renal stones are made of calcium oxalate and calcium phosphate. The main identified risks for calcium renal stone formation are hypercalciuria and urinary saturation. A urine phosphate (Pi) loss is often associated with hypercalciuria; furthermore, hyperphosphaturia increases urinary saturation.
METHODS: To determine whether urinary phosphate loss is associated with calcium urolithiasis, we measured renal Pi threshold (TmPi) in 207 stone formers with normal parathyroid hormone (PTH) serum concentration and in 105 control subjects.
RESULTS: The TmPi followed a normal distribution in both groups. The mean TmPi was significantly lower in stone formers versus controls (0.72 +/- 0.13 vs. 0.87 +/- 0.18 mmol/L, P < 0.0001) because of a shift to the left of the TmPi distribution curve in the stone former population, with no evidence for bimodal distribution. Five percent of the controls had a TmPi <0.63 versus 19% of the stone formers. Daily urinary calcium excretion was significantly higher in stone formers than in controls. Calcium excretion was also significantly higher in stone formers with TmPi <0.63 mmol/L compared with those with TmPi > or =0.63. Serum PTH and ionized calcium concentrations were not different in stone formers and in control subjects, whatever the TmPi value.
CONCLUSIONS: : A low TmPi is more frequently encountered in stone formers with a normal PTH concentration than in control subjects and is associated with a high urinary Ca excretion. The hypophosphatemia induced by a renal phosphate leak may predispose the subject to calcium stone formation by increasing the serum calcitriol level, calcium excretion, and urinary saturation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422761     DOI: 10.1046/j.1523-1755.2001.00796.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis.

Authors:  Armando Luis Negri; Rodolfo Spivacow; Elisa Del Valle; Erich Fradinger; Alicia Marino; Jose Ruben Zanchetta
Journal:  Urol Res       Date:  2003-09-13

2.  Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis.

Authors:  Yun-Sok Ha; Dong-Un Tchey; Ho Won Kang; Yong-June Kim; Seok-Joong Yun; Sang-Cheol Lee; Wun-Jae Kim
Journal:  Korean J Urol       Date:  2010-01-21

Review 3.  Bone disease in pediatric idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2012-04-06

4.  Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis.

Authors:  Ali Amar; Amar J Majmundar; Ihsan Ullah; Ayesha Afzal; Daniela A Braun; Shirlee Shril; Ankana Daga; Tilman Jobst-Schwan; Mumtaz Ahmad; John A Sayer; Heon Yung Gee; Jan Halbritter; Thomas Knöpfel; Nati Hernando; Andreas Werner; Carsten Wagner; Shagufta Khaliq; Friedhelm Hildebrandt
Journal:  Hum Genet       Date:  2019-02-18       Impact factor: 4.132

5.  Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.

Authors:  Eric N Taylor; Andrew N Hoofnagle; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-26       Impact factor: 8.237

6.  Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers.

Authors:  Kristin J Bergsland; Fredric L Coe; Joan H Parks; John R Asplin; Elaine M Worcester
Journal:  Nephrol Dial Transplant       Date:  2018-05-01       Impact factor: 5.992

7.  Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures.

Authors:  P Wong; P J Fuller; M T Gillespie; V Kartsogiannis; B J Strauss; D Bowden; F Milat
Journal:  Osteoporos Int       Date:  2013-01-05       Impact factor: 4.507

8.  Bone disease in primary hypercalciuria.

Authors:  Stefania Sella; Catia Cattelan; Giuseppe Realdi; Sandro Giannini
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

Review 9.  New insights into the pathogenesis of idiopathic hypercalciuria.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

10.  Renal phosphate-transporter regulatory proteins and nephrolithiasis.

Authors:  Moshe Levi; Sophia Breusegem; Sophia Bruesegem
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.